
A new drug to treat type 2 diabetes has been approved for use) in the UK. Tirzepatide (sold under the brand name Mounjaro) could be available for prescription by early 2024 – subject to availability.
Mounjaro is an injectable treatment that helps the body to both control blood glucose (sugars) after meals and regulate appetite. Research into the drug has shown it’s more effective in controlling blood sugar and leads to greater weight loss compared with the type 2 diabetes drugs currently available for prescription.